{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:41:27Z","timestamp":1792190487623,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In rheumatoid arthritis (RA), the persistence of pain despite adequate inflammatory control may indicate the involvement of nociplastic and\/or neuropathic pain (NP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the presence of central sensitization (CS) and\/or NP in patients with RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This descriptive, cross-sectional study used convenience sampling and included adult patients (\u2265\u200918 years) with RA diagnosed according to the 2010 classification criteria of the American College of Rheumatology \u2013 ACR. The following instruments were applied: Central Sensitization Inventory (CSI), PainDETECT Questionnaire (PD-Q), and the 2010\/2011 ACR criteria for fibromyalgia (FM), revised in 2016 (the latter applied only to patients with CSI\u2009\u2265\u200940). Descriptive and predictive analyses were conducted with a significance level of 5%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 113 patients were included (mean age 54.3 years; 93.81% female; mean disease duration 12.11 years). CS was identified in 59.29% of patients; among them, 47.76% met FM criteria, while 52.24% did not. Among patients with CS, 53.73% reported severe pain (Numeric Rating Scale, NRS), and 44.78% had high disease activity (Clinical Disease Activity Index, CDAI). CSI was a significant predictor of both NRS and CDAI in univariate (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and multivariate analyses (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.037 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009, respectively). According to PD-Q, 17.70% of patients had probable NP, and PD-Q scores were predictive of CDAI, NRS, and CSI (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Among patients with CS, 26.87% also showed overlapping NP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A substantial proportion of RA patients presented with CS-related pain, even in the absence of FM, suggesting a mixed (\u201ctop-down and bottom-up\u201d) nociplastic pain profile. Both CS and NP were associated with higher pain levels and increased disease activity. This is the first Brazilian study to characterize the coexistence of CS-related pain (with or without FM) and NP in RA, offering relevant insights for the clinical management of chronic pain in this population. These findings reinforce that routine screening and assessment of CS and NP should be an integral and continuous component of RA management, preceding therapeutic adjustments and extending throughout follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42358-025-00487-y","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:37:55Z","timestamp":1761903475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Neuropathic pain and central sensitization in patients with rheumatoid arthritis attending a tertiary hospital"],"prefix":"10.1186","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5967-4862","authenticated-orcid":false,"given":"Maria Nathalia Gabriela Rocha","family":"Pontes de Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8441-2756","authenticated-orcid":false,"given":"D\u00e9bora","family":"de Jesus\u00a0Sena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4809-9965","authenticated-orcid":false,"given":"Ana Karla Guedes","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8236-024X","authenticated-orcid":false,"given":"Danielle C. Soares","family":"Egypto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6737-1760","authenticated-orcid":false,"given":"Lu\u00eds F\u00e1bio Barbosa","family":"Botelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7515-3947","authenticated-orcid":false,"given":"Alessandra","family":"de Sousa\u00a0Braz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"487_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5935\/2595-0118.20200010","volume":"3","author":"GH Dion\u00edsio","year":"2020","unstructured":"Dion\u00edsio GH, Salermo VY, Padilha A. Central sensitization and beliefs among patients with chronic pain in a primary health care unit. Braz J Pain. 2020;3:42\u20137. https:\/\/doi.org\/10.5935\/2595-0118.20200010.","journal-title":"Braz J Pain"},{"key":"487_CR2","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.3390\/jcm10153203","volume":"10","author":"J Nijs","year":"2021","unstructured":"Nijs J, Lahousse A, Kapreli E, Bilika P, Sara\u00e7o\u011flu \u0130, Malfliet A, et al. Nociplastic pain criteria or recognition of central sensitization? Pain phenotyping in the past, present and future. J Clin Med. 2021;10:3203. https:\/\/doi.org\/10.3390\/jcm10153203.","journal-title":"J Clin Med"},{"key":"487_CR3","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3390\/life13030694","volume":"13","author":"C Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2023","unstructured":"Fern\u00e1ndez-de-las-Pe\u00f1as C, Nijs J, Cagnie B, Gerwin RD, Plaza-Manzano G, Valera-Calero JA, et al. Myofascial pain syndrome: A nociceptive condition comorbid with neuropathic or nociplastic pain. Life (Basel). 2023;13:694. https:\/\/doi.org\/10.3390\/life13030694.","journal-title":"Life (Basel)"},{"key":"487_CR4","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","volume":"161","author":"SN Raja","year":"2020","unstructured":"Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, et al. The revised international association for the study of pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161:1976\u201382. https:\/\/doi.org\/10.1097\/j.pain.0000000000001939.","journal-title":"Pain"},{"key":"487_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2665-9913(21)00032-1","volume":"3","author":"J Nijs","year":"2021","unstructured":"Nijs J, George SZ, Clauw DJ, Fern\u00e1ndez-de-las-Pe\u00f1as C, Kosek E, Ickmans K, et al. Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine. Lancet Rheumatol. 2021;3:383\u201392. https:\/\/doi.org\/10.1016\/S2665-9913(21)00032-1.","journal-title":"Lancet Rheumatol"},{"key":"487_CR6","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas da Artrite Reumatoide. Gov.Br. 2021. Available from: https:\/\/www.gov.br\/conitec\/pt-br\/midias\/consultas\/relatorios\/2020\/relatrio_artrite_reumatoide_cp_21_2020.pdf. Accessed 22 Feb 2024."},{"key":"487_CR7","unstructured":"Shinjo SK, Moreira C. Livro da Sociedade Brasileira de Reumatologia. 2o ed. Manole; 2020."},{"issue":"5","key":"487_CR8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","volume":"41","author":"K Almutairi","year":"2021","unstructured":"Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. 2021;41(5):863\u201377. https:\/\/doi.org\/10.1007\/s00296-020-04731-0.","journal-title":"Rheumatol Int"},{"issue":"2","key":"487_CR9","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/rheumatology\/kead694","volume":"64","author":"M Doumen","year":"2025","unstructured":"Doumen M, Stouten V, Pazmino S, De Meyst E, Bertrand D, Joly J. Patient-physician discordance impairs outcomes in early rheumatoid arthritis through less consistent treat-to-target implementation. Rheumatology (Oxford). 2025;64(2):821\u20135. https:\/\/doi.org\/10.1093\/rheumatology\/kead694.","journal-title":"Rheumatology (Oxford)"},{"issue":"13","key":"487_CR10","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: A review. JAMA. 2018;320(13):1360\u201372. https:\/\/doi.org\/10.1001\/jama.2018.13103.","journal-title":"JAMA"},{"key":"487_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X21993252","author":"G Adami","year":"2021","unstructured":"Adami G, Gerratana E, Atzeni F, Benini C, Vantaggiato E, Rotta D, et al. Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? Ther Adv Musculoskelet Dis. 2021. https:\/\/doi.org\/10.1177\/1759720X21993252.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"487_CR12","unstructured":"Braz AS, Ranzolin A, Heymann RE. Dores Musculoesquel\u00e9ticas Localizadas e Difusas. 3o ed. Manole; 2022."},{"issue":"1","key":"487_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bjane.2021.06.013","volume":"72","author":"JV Bittencourt","year":"2022","unstructured":"Bittencourt JV, Corr\u00eaa LA, Freynhagen R, Dos Reis FJJ, Melo TB, et al. Cross-cultural adaptation of the paindetect questionnaire into Brazilian Portuguese. Braz J Anesthesiol. 2022;72(1):44\u20138. https:\/\/doi.org\/10.1016\/j.bjane.2021.06.013.","journal-title":"Braz J Anesthesiol"},{"issue":"2","key":"487_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/papr.12440","volume":"17","author":"R Neblett","year":"2017","unstructured":"Neblett R, Hartzell MM, Mayer TG, Cohen H, Gatchel RJ. Establishing clinically relevant severity levels for the central sensitization inventory. Pain Pract. 2017;17(2):166\u201375. https:\/\/doi.org\/10.1111\/papr.12440.","journal-title":"Pain Pract"},{"issue":"5","key":"487_CR15","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600\u201310. https:\/\/doi.org\/10.1002\/acr.20140.","journal-title":"Arthritis Care Res"},{"issue":"4","key":"487_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ajem.2018.01.008","volume":"36","author":"O Karcioglu","year":"2018","unstructured":"Karcioglu O, Topacoglu H, Dikme O, Dikme O. A systematic review of the pain scales in adults: which to use? Am J Emerg Med. 2018;36(4):707\u201314. https:\/\/doi.org\/10.1016\/j.ajem.2018.01.008.","journal-title":"Am J Emerg Med"},{"key":"487_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42358-020-0121-5","volume":"60","author":"N Sacilotto","year":"2020","unstructured":"Sacilotto N, de Giorgi C, Vargas-Santos RDN, Albuquerque AB, de Radominski CP, Pereira SC, Guimar\u00e3es IA. Rheumatoid arthritis in real life - study cohort: a sociodemographic profile of rheumatoid arthritis in Brazil [Internet]. Adv Rheumatol. 2020;60:1\u20139. https:\/\/doi.org\/10.1186\/s42358-020-0121-5.","journal-title":"Adv Rheumatol"},{"key":"487_CR18","doi-asserted-by":"publisher","unstructured":"Leng X, Leszczy\u0144ski P, Jeka S, Liu SY, Liu H, Miakisz M et al. Comparing Tocilizumab biosimilar BAT1806\/BIIB800 with reference Tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trial published correction appears in lancet rheumatol. 2024;6(3):e140. https:\/\/doi.org\/10.1016\/S2665-99132400031-6","DOI":"10.1016\/S2665-99132400031-6"},{"issue":"5","key":"487_CR19","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1080\/14397595.2019.1650462","volume":"30","author":"K Noda","year":"2020","unstructured":"Noda K, Tajima M, Oto Y, Saitou M, Yoshiga M, Otani K, et al. How do neuropathic pain-like symptoms affect health-related quality of life among patients with rheumatoid arthritis? A comparison of multiple pain-related parameters. Mod Rheumatol. 2020;30(5):828\u201334. https:\/\/doi.org\/10.1080\/14397595.2019.1650462.","journal-title":"Mod Rheumatol"},{"issue":"5","key":"487_CR20","doi-asserted-by":"publisher","first-page":"980","DOI":"10.55563\/clinexprheumatol\/msy022","volume":"40","author":"M Saitou","year":"2022","unstructured":"Saitou M, Noda K, Matsushita T, Ukichi T, Kurosaka D. Central sensitisation features are associated with neuropathic pain-like symptoms in patients with longstanding rheumatoid arthritis: a cross-sectional study using the central sensitisation inventory. Clin Exp Rheumatol. 2022;40(5):980\u20137. https:\/\/doi.org\/10.55563\/clinexprheumatol\/msy022.","journal-title":"Clin Exp Rheumatol"},{"key":"487_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s42358-018-0042-8","volume":"59","author":"S Rocha","year":"2019","unstructured":"Rocha S, de Baldo B, Andrade DC. Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis. Adv Rheumatol. 2019;59:2. https:\/\/doi.org\/10.1186\/s42358-018-0042-8.","journal-title":"Adv Rheumatol"},{"issue":"11","key":"487_CR22","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1136\/ard-2023-225327","volume":"83","author":"DJ Clauw","year":"2024","unstructured":"Clauw DJ. From fibrositis to fibromyalgia to nociplastic pain: how rheumatology helped get Us here and where do we go from here? Ann Rheum Dis. 2024;83(11):1421\u20137. https:\/\/doi.org\/10.1136\/ard-2023-225327.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"487_CR23","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/acr.24596","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR, et al. American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2021;73(7):924\u201339. https:\/\/doi.org\/10.1002\/acr.24596.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"487_CR24","unstructured":"Brasil M. da S. Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no SUS. Artrite Reumatoide: relat\u00f3rio de recomenda\u00e7\u00e3o. Gov.Br 2020."},{"issue":"11","key":"487_CR25","doi-asserted-by":"publisher","first-page":"103423","DOI":"10.1016\/j.autrev.2023.103423","volume":"22","author":"P Sarzi-Puttini","year":"2023","unstructured":"Sarzi-Puttini P, Zen M, Arru F, Giorgi V, Choy EA. Residual pain in rheumatoid arthritis: is it a real problem? Autoimmun Rev. 2023;22(11):103423. https:\/\/doi.org\/10.1016\/j.autrev.2023.103423.","journal-title":"Autoimmun Rev"},{"issue":"8","key":"487_CR26","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/rheumatology\/key112","volume":"57","author":"SJ Duffield","year":"2018","unstructured":"Duffield SJ, Miller N, Zhao S, Goodson NJ. Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2018;57(8):1453\u201360. https:\/\/doi.org\/10.1093\/rheumatology\/key112.","journal-title":"Rheumatology (Oxford)"},{"key":"487_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s40674-019-00125-x","volume":"5","author":"L Meert","year":"2019","unstructured":"Meert L, Smeets RJEM, Baert I, Mertens M, Boonen A, Meeus M. Treatment of central sensitization in patients with rheumatoid arthritis: a narrative overview. Curr Treat Options Rheum. 2019;5:179\u201389. https:\/\/doi.org\/10.1007\/s40674-019-00125-x.","journal-title":"Curr Treat Options Rheum"},{"issue":"2","key":"487_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.14744\/nci.2023.81231","volume":"11","author":"N Mesci","year":"2024","unstructured":"Mesci N, Mesci E, Kandemir EU, Kulcu DG, Celik T. Impact of central sensitization on clinical parameters in patients with rheumatoid arthritis. North Clin Istanb. 2024;11(2):140\u20136. https:\/\/doi.org\/10.14744\/nci.2023.81231. Published 2024 Apr 22.","journal-title":"North Clin Istanb"},{"issue":"1","key":"487_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10067-019-04749-1","volume":"39","author":"MA Guler","year":"2020","unstructured":"Guler MA, Celik OF, Ayhan FF. The important role of central sensitization in chronic musculoskeletal pain seen in different rheumatic diseases. Clin Rheumatol. 2020;39(1):269\u201374. https:\/\/doi.org\/10.1007\/s10067-019-04749-1.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"487_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4078\/jrd.22.0047","volume":"30","author":"DH Lim","year":"2023","unstructured":"Lim DH. A challenging target: persistent pain during the remission state in rheumatoid arthritis patients. J Rheum Dis. 2023;30(1):1\u20132. https:\/\/doi.org\/10.4078\/jrd.22.0047.","journal-title":"J Rheum Dis"},{"issue":"3","key":"487_CR31","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s10787-022-00995-z","volume":"30","author":"F Salaffi","year":"2022","unstructured":"Salaffi F, Carotti M, Farah S, Ceccarelli L, Giovagnoni A, Di Carlo M. Early response to JAK inhibitors on central sensitization and pain catastrophizing in patients with active rheumatoid arthritis. Inflammopharmacology. 2022;30(3):1119\u201328. https:\/\/doi.org\/10.1007\/s10787-022-00995-z.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"487_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40674-019-00116-y","volume":"14","author":"JT Golenbiewski","year":"2019","unstructured":"Golenbiewski JT, Pisetsky DS. A holistic approach to pain management in the rheumatic diseases. Curr Treat Options Rheumatol. 2019;14(1):1\u201310. https:\/\/doi.org\/10.1007\/s40674-019-00116-y.","journal-title":"Curr Treat Options Rheumatol"},{"issue":"8","key":"487_CR33","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/papr.13162","volume":"22","author":"F Salaffi","year":"2022","unstructured":"Salaffi F, Farah S, Mariani C, Sarzi-Puttini P, Di Carlo M. Validity of the central sensitization inventory compared with traditional measures of disease severity in fibromyalgia. Pain Pract. 2022;22(8):702\u201310. https:\/\/doi.org\/10.1111\/papr.13162.","journal-title":"Pain Pract"},{"key":"487_CR34","doi-asserted-by":"publisher","unstructured":"Garip Y, Eser F, Kilicarslan A, Bodur H. Prevalence of neuropathic pain in rheumatic disorders: association with disease activity, functional status and quality of life. Archives Rheumatol. 2015;30(3). https:\/\/doi.org\/10.5606\/ArchRheumatol.2015.5295.","DOI":"10.5606\/ArchRheumatol.2015.5295"},{"issue":"1","key":"487_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13075-015-0761-8","volume":"17","author":"SM Koop","year":"2015","unstructured":"Koop SM, ten Klooster PM, Vonkeman HE, Steunebrink LM, van de Laar MA. Neuropathic-like pain features and cross-sectional associations in rheumatoid arthritis. Arthritis Res Ther. 2015;17(1):237. https:\/\/doi.org\/10.1186\/s13075-015-0761-8.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"487_CR36","first-page":"291","volume":"43","author":"RT Martins","year":"2018","unstructured":"Martins RT, Pimenta S, Bernardo A, Bernardes M, Barbosa M, Lucas R, et al. Determinants of non-nociceptive pain in rheumatoid arthritis. Determinants of non-nociceptive pain in rheumatoid arthritis. Acta Reumatol Port. 2018;43(4):291\u2013303.","journal-title":"Acta Reumatol Port"},{"key":"487_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s42358-022-00238-3","volume":"62","author":"FA Pereira","year":"2022","unstructured":"Pereira FA, Louren\u00e7o MA, Assis MR. Evaluation of peripheral neuropathy in lower limbs of patients with rheumatoid arthritis and its relation to fall risk. Adv Rheumatol. 2022;62:9. https:\/\/doi.org\/10.1186\/s42358-022-00238-3.","journal-title":"Adv Rheumatol"},{"key":"487_CR38","doi-asserted-by":"publisher","unstructured":"Radwan A, Borai A. Neuropathic pain in a sample of Egyptian patients with rheumatoid arthritis. Egypt Rheumatol Rehabil. 2020;47. https:\/\/doi.org\/10.1186\/s43166-020-00047-w.","DOI":"10.1186\/s43166-020-00047-w"},{"key":"487_CR39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s40674-021-00178-x","volume":"7","author":"M Di Carlo","year":"2021","unstructured":"Di Carlo M, Smerilli G, Salaffi F. Mechanisms and mediators of pain in chronic inflammatory arthritis. Curr Treat Options Rheum. 2021;7:194\u2013207. https:\/\/doi.org\/10.1007\/s40674-021-00178-x.","journal-title":"Curr Treat Options Rheum"},{"issue":"4","key":"487_CR40","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/ph16040587","volume":"16","author":"JM De Souza","year":"2023","unstructured":"De Souza JM, Trevisan TJ, Sepresse SR, Londe AC, Fran\u00e7a J\u00fanior MC, Appenzeller S. Peripheral neuropathy in systemic autoimmune rheumatic Diseases-Diagnosis and treatment. Pharmaceuticals (Basel). 2023;16(4):587. https:\/\/doi.org\/10.3390\/ph16040587.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"52","key":"487_CR41","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.3346\/jkms.2018.33.e346","volume":"33","author":"JJ Song","year":"2018","unstructured":"Song JJ, Song YW, Bae SC, Cha HS, Choe JY, Choi SJ, et al. Treat-to-Target strategy for Asian patients with early rheumatoid arthritis: result of a multicenter trial in Korea. J Korean Med Sci. 2018;33(52):e346. https:\/\/doi.org\/10.3346\/jkms.2018.33.e346.","journal-title":"J Korean Med Sci"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00487-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-025-00487-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00487-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:37:57Z","timestamp":1761903477000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-025-00487-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["487"],"URL":"https:\/\/doi.org\/10.1186\/s42358-025-00487-y","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Regarding ethical aspects, this study was approved by the Medical Ethics Committee of the Center for Medical Sciences at UFPB (CAAE No. 70626623.6.0000.5183), in compliance with ethical guidelines outlined in CNS Resolution No. 466\/2012 of the Brazilian Ministry of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All participants agreed to take part in the study by providing authorization through the Informed Consent Form before data collection. The identities of research volunteers were appropriately protected.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Footnotes"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}